Given the obesity epidemic in the United States and its adverse association with breast cancer outcomes, especially in the setting of a disease that is aggressive and lacks effective targeted therapeutic options, we sought to examine the impact of weight change during NCT for TNBC on Ki-67 and pathologic response. The gene discussed is MKI67; the disease is obesity due to melanocortin 4 receptor deficiency.